Kaplan JL, Bousvaros A, Turner D, Dubinsky M, et al. Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial. Lancet Gastroenterol Hepatol 2025 Nov 18:S2468-1253(25)00196.
PMID: 41270771